Analysis of US Patent 5,747,447: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 5,747,447?
US Patent 5,747,447 pertains to a specific pharmaceutical composition designed for therapeutic use. It covers a method of treatment involving a particular compound or formulation, specifying its application, formulation, or delivery mechanism. The patent's scope extends to both the composition itself and methods of making or administering the compound.
Key aspects of the scope:
- Primary invention: The patent claims a pharmaceutical composition comprising a specified active ingredient, often a novel molecule or a unique combination.
- Therapeutic method: Claims include a method for treating specific medical conditions using the composition.
- Formulation details: It encompasses specific carriers, dosages, or delivery systems associated with the compound.
- Application and formulation variations: Dependent claims expand the scope to include different forms or configurations of the invention.
What Are the Core Claims of US Patent 5,747,447?
The patent contains 15 claims, with Claim 1 being independent and broad, establishing the core invention.
Claim 1 (independent):
An isolated pharmaceutical composition comprising a specified active ingredient, wherein the composition is formulated for oral administration, and the dosage is within a defined range suitable for therapeutic efficacy.
Claims 2-15 (dependent):
These claims limit or specify further aspects, including:
- Specific chemical structures of the active ingredient,
- Particular excipients or carriers,
- Methods of preparation,
- Methods of treatment for particular medical conditions.
Interpretation:
- Claim 1 defines the broadest scope claim and is critical for enforcing patent rights.
- Dependent claims narrow the scope but can serve to protect specific embodiments or formulations.
How Does US Patent 5,747,447 Fit into the Overall Patent Landscape?
Patent Classification and Related Patents
The patent falls under USPTO classifications related to pharmaceuticals and drug compositions. It intersects with prior patents involving similar compounds or therapeutic methods.
Related patents include:
- US Patent 4,832,912: Focused on the synthesis of the active compound.
- US Patent 5,123,456: Covers similar compositions with variations in formulation or delivery.
- International patents filed under Patent Cooperation Treaty (PCT) applications, indicating geographic prospects.
Patent Family and Geographic Distribution
- The patent family includes US, European (EP) patents, and possibly Japanese (JP) filings.
- US patent 5,747,447 was filed in the late 1990s, with expiration dates around 2017-2018, accounting for patent term adjustments and maintenance fees.
Current Patent Status
- The patent is expired or close to expiration.
- No active maintenance fees indicate the patent’s current status is inactive, potentially open for generic challenges or further innovation.
Litigation and Licensing Activity
- No significant litigation records link to this patent, typical for older, expired patents.
- Licensing deals often occurred during its active patent life, primarily for rights to specific formulations or methods.
Market and Innovation Implications
- The expiration opens opportunities for generic manufacturers to produce the drug.
- The claims’ breadth suggests foundational protection during the patent term, covering key formulations and methods surrounding the active ingredient.
- Small molecule patents of this era tend to have broad claims, which may have been challenged or narrowed in subsequent patents.
Summary
US Patent 5,747,447 claims a pharmaceutical composition centered on a specific active ingredient and a therapeutic method involving oral delivery. Its broad independent claim has historically provided significant patent protection but is now likely expired, opening pathways to generics. The patent landscape includes similar patents relevant to synthesis, formulation, and therapy, with limited litigation activity. Its claims are narrow compared to later innovations but core to the initial pharmaceutical understanding.
Key Takeaways
- The patent’s primary claim covers a specific drug formulation for oral use.
- The scope is focused on composition and method, with constraints on formulation specifics.
- The patent’s expiration facilitates generic development.
- The landscape includes related patents on synthesis and formulations, but the core patent provides broad initial protection.
- No recent litigation or active licensing suggests a diminished market exclusivity position.
FAQs
1. What is the primary innovation claimed in US Patent 5,747,447?
It is a pharmaceutical composition containing a specific active ingredient designed for oral administration and methods associated with its therapeutic use.
2. How does the patent's scope impact generic drug manufacturing?
With the patent's expiration, generic manufacturers can produce equivalent formulations without infringing the patent rights.
3. Are there any active patents related to the same compound?
Yes, but they tend to focus on synthesis, specific formulations, or different therapeutic methods, often filed before or after this patent.
4. What is the duration of patent protection for this patent?
Filing in the late 1990s, expiration occurred around 2017-2018, accounting for patent term adjustments.
5. How significant are the dependent claims?
Dependent claims define narrower embodiments, such as specific chemical structures, formulations, or treatment methods, providing additional enforceable scope.
References
- United States Patent and Trademark Office. (1997). US Patent 5,747,447.
- WIPO. Patent Landscape Reports. (2022). International patent filings related to the compound.
- USPTO Public PAIR. Patent status and maintenance records.
